Bharat Biotech Ltd.
Bharat Biotech Ltd., a prominent player in the biotechnology sector, is headquartered in Hyderabad, India. Founded in 1996, the company has established itself as a leader in vaccine development and biopharmaceuticals, focusing on innovative solutions for infectious diseases. With a robust portfolio that includes vaccines for diseases such as typhoid, hepatitis, and COVID-19, Bharat Biotech is renowned for its commitment to research and development. The company’s unique approach combines cutting-edge technology with a strong emphasis on safety and efficacy, setting it apart in the competitive landscape. Recognised for its significant contributions to public health, Bharat Biotech has achieved notable milestones, including the development of India’s first indigenous COVID-19 vaccine. Its strategic operations extend across various regions, reinforcing its position as a key player in the global biotechnology industry.
DitchCarbon Score
How does Bharat Biotech Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bharat Biotech Ltd.'s score of 9 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bharat Biotech Ltd.'s reported carbon emissions
Bharat Biotech Ltd., headquartered in India, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions data, it is important to note that Bharat Biotech has not outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi) or similar climate pledges. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the biopharmaceutical industry increasingly prioritises sustainability, Bharat Biotech's future climate commitments and initiatives will be crucial for aligning with global efforts to reduce greenhouse gas emissions and combat climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bharat Biotech Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
